<DOC>
	<DOCNO>NCT02963129</DOCNO>
	<brief_summary>Compare frequency epistaxis quality life relate nasal bleeding patient HHT colonize sataphylococo treat mupirocin ointment .</brief_summary>
	<brief_title>Treatment Nasal Staphylococcus Aureus Colonization Patients With HHT</brief_title>
	<detailed_description>Hereditary hemorrhagic telangiectasia vascular dysplasia characterize development mucocutaneous telangiectasia arteriovenous malformation organ brain , lung , liver tube digestivo . Is consider rare disease , although It mean substantial underdiagnosis . The overall prevalence 1/5000 . Approximately 60 % general population host strain Staphylococcus aureus ( S. aureus ) intermittently call intermittent carrier , 20 % represent persistent carrier harbor strain S. aureus 20 % population never carrier . On concept , one might think HHT patient active pathological vascular remodel cause bleed , inflammation know activator abnormal angiogenesis ; reduce inflammatory factor microbial eradication nasal S. aureus could useful reduce bleed population , directly impact quality life .</detailed_description>
	<mesh_term>Telangiectasis</mesh_term>
	<mesh_term>Epistaxis</mesh_term>
	<mesh_term>Telangiectasia , Hereditary Hemorrhagic</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<criteria>Patients 18 year possible confirm HHT diagnostic criterion Cura√ßao . Patients nasal S. aureus colonization culture positive Refusal participate study informed consent process . Hypersensitivity contraindication topical mupirocin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hereditary Hemorrhagic Telangiectasia</keyword>
	<keyword>Epistaxis</keyword>
</DOC>